Stanislawski Pauline C, Willis Anthony C, Banwell Martin G
Research School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 0200, Australia.
Chem Asian J. 2007 Sep 3;2(9):1127-36. doi: 10.1002/asia.200700155.
ent-Erythramine ((-)-1), the enantiomer of the alkaloid erythramine, was prepared in 15 steps from known compounds. The first of three pivotal bond-forming steps in the synthesis was a Suzuki-Miyaura cross-coupling reaction of the starting materials to give a bis-silyl ether. The second involved silver(I)-induced electrocyclic ring opening of the gem-dichlorocyclopropane formed in the next step and trapping of the ensuing pi-allyl cation by the tethered nitrogen atom to give, following cleavage of the allyloxycarbonyl protecting group, an approximately 5:6 mixture of the chromatographically separable diastereoisomeric spirocyclic products. In the third critical bond-forming reaction, the iodide formed from one of the diastereoisomers underwent a radical-addition/elimination reaction sequence that led to (-)-1 in 89 % yield. The application of the same sequence of transformations to the other diastereoisomer afforded 3-epi-(+)-erythramine (3-epi-(+)-1).
对映体-刺桐胺((-)-1),即生物碱刺桐胺的对映体,由已知化合物经15步反应制备而成。合成过程中的三个关键成键步骤中的第一步是起始原料的铃木-宫浦交叉偶联反应,生成双硅醚。第二步涉及银(I)诱导的下一步形成的偕二氯环丙烷的电环化开环反应,以及通过相连的氮原子捕获随后生成的π-烯丙基阳离子,在烯丙氧羰基保护基裂解后,得到色谱可分离的非对映异构螺环产物的约5:6混合物。在第三个关键成键反应中,由其中一个非对映异构体形成的碘化物经历自由基加成/消除反应序列,以89%的产率得到(-)-1。将相同的转化序列应用于另一个非对映异构体,得到3-表-(+)-刺桐胺(3-表-(+)-1)。